Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 17 studies | 34% ± 17% | |
| lung | 12 studies | 24% ± 8% | |
| peripheral blood | 11 studies | 33% ± 19% | |
| intestine | 7 studies | 20% ± 8% | |
| eye | 7 studies | 27% ± 11% | |
| heart | 5 studies | 23% ± 3% | |
| kidney | 4 studies | 20% ± 4% | |
| liver | 4 studies | 35% ± 13% | |
| adipose | 4 studies | 24% ± 5% | |
| bone marrow | 3 studies | 18% ± 2% | |
| lymph node | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3893.53 | 1445 / 1445 | 100% | 18.30 | 183 / 183 |
| prostate | 100% | 5444.20 | 245 / 245 | 100% | 12.15 | 501 / 502 |
| breast | 100% | 5610.24 | 459 / 459 | 100% | 20.18 | 1115 / 1118 |
| thymus | 100% | 6473.94 | 653 / 653 | 99% | 17.79 | 601 / 605 |
| lung | 100% | 5491.24 | 578 / 578 | 99% | 14.54 | 1147 / 1155 |
| bladder | 100% | 4585.00 | 21 / 21 | 99% | 12.04 | 499 / 504 |
| brain | 99% | 2847.19 | 2615 / 2642 | 100% | 20.00 | 705 / 705 |
| intestine | 100% | 5085.43 | 966 / 966 | 99% | 10.84 | 521 / 527 |
| uterus | 100% | 5934.94 | 170 / 170 | 99% | 12.28 | 453 / 459 |
| pancreas | 100% | 3806.10 | 328 / 328 | 98% | 12.33 | 175 / 178 |
| stomach | 100% | 3855.88 | 359 / 359 | 98% | 12.42 | 281 / 286 |
| ovary | 100% | 6585.73 | 180 / 180 | 98% | 11.51 | 422 / 430 |
| adrenal gland | 100% | 3621.33 | 258 / 258 | 96% | 7.97 | 220 / 230 |
| skin | 100% | 5511.15 | 1809 / 1809 | 95% | 13.44 | 449 / 472 |
| kidney | 100% | 3714.51 | 89 / 89 | 94% | 11.31 | 850 / 901 |
| liver | 100% | 2599.40 | 226 / 226 | 86% | 7.90 | 351 / 406 |
| adipose | 100% | 5105.43 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.11 | 29 / 29 |
| spleen | 100% | 8352.53 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.28 | 1 / 1 |
| blood vessel | 100% | 3466.95 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2489.74 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 2745.98 | 855 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 4368.06 | 911 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 9.11 | 42 / 45 |
| eye | 0% | 0 | 0 / 0 | 76% | 6.93 | 61 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0042177 | Biological process | negative regulation of protein catabolic process |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0003181 | Biological process | atrioventricular valve morphogenesis |
| GO_0003203 | Biological process | endocardial cushion morphogenesis |
| GO_0003281 | Biological process | ventricular septum development |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0065003 | Biological process | protein-containing complex assembly |
| GO_0003283 | Biological process | atrial septum development |
| GO_0003170 | Biological process | heart valve development |
| GO_0043066 | Biological process | negative regulation of apoptotic process |
| GO_0050821 | Biological process | protein stabilization |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0071456 | Biological process | cellular response to hypoxia |
| GO_0030330 | Biological process | DNA damage response, signal transduction by p53 class mediator |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0017053 | Cellular component | transcription repressor complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0019899 | Molecular function | enzyme binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MDM4 |
| Protein name | MDM4 regulator of p53 Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4) Mdm4 p53 binding protein transcript variant B MDM4 protein variant G (MDM4 protein variant Y) (MDM4 regulator of p53) (cDNA FLJ56709, highly similar to Mdm4 protein) |
| Synonyms | MDMX DKFZp781B1423 |
| Description | FUNCTION: Along with MDM2, contributes to TP53 regulation . Inhibits p53/TP53- and TP73/p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Inhibits degradation of MDM2. Can reverse MDM2-targeted degradation of TP53 while maintaining suppression of TP53 transactivation and apoptotic functions. . |
| Accessions | Q5T0Y3 ENST00000612738.4 ENST00000616250.4 ENST00000391947.6 A0A087WUE3 Q5T0Y4 M9UVU3 Q5T0Y2 ENST00000454264.6 [O15151-5] ENST00000614459.4 Q68DC0 O15151 ENST00000367179.7 A0A087WZ58 ENST00000444261.1 ENST00000367180.5 A0A087WTR9 ENST00000367183.7 [O15151-4] ENST00000367182.8 [O15151-1] ENST00000507825.3 |